The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

This drug, marketed for other uses, is drawing young adults into devastating addictions -and sometimes fatal consequences.

Aptar Digital Health's HeroTracker® Sense has been granted by the U.S Food and Drug Administration 510(k) clearance as a ...

October 21, 2025 - Nanoform Finland Plc (“Nanoform”), a leading nanoparticle medicine performance-enhancing company, today announced that key findings from two proof-of-concept studies conducted in ...

Phase II trial shows belzutifan effectively shrinks rare neuroendocrine tumors and improves symptoms, offering hope for ...

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

You've probably smelled it at the club or in the pit of a concert, but you better wise up, because it's back on the wider club scene.

A Newton County jury has decided the fate of a man convicted of trafficking and distributing numerous drugs out of his home ...

While the International Agency for Research on Cancer only goes as far as to say talc is "probably" carcinogenic, asbestos ...

Nitrous oxide is known as the chemical compound used in dental procedures to reduce pain. But the FDA is warning of its abuse ...

Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...

DelveInsight's Emphysema Market Insights report includes a comprehensive understanding of current treatment practices, emphysema emerging drugs, market share of individual therapies, and current and ...